Molecular pathogenesis of human prolactinomas identified by gene expression profiling, RT-qPCR, and proteomic analyses

Pituitary

Volumn 11, Issue 3, 2008, Pages 231-245

  Evans, Chheng Orn ^a   Moreno, Carlos S ^a   Zhan, Xianquan ^b   McCabe, Michael T ^a   Vertino, Paula M ^a   Desiderio, Dominic M ^b   Oyesiku, Nelson M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Gene expression profiling; Pituitary adenomas; Prolactinomas; Proteomics; Realtime quantitative PCR

Indexed keywords

ANGIOPOIETIN 1; BAG 1 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1C; DNA; FIBROCYSTIN; GALANIN; GROWTH HORMONE; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; HIGH MOBILITY GROUP PROTEIN; IMMUNOGLOBULIN; INITIATION FACTOR 3; MITOGEN ACTIVATED PROTEIN KINASE 1; NERVE CELL ADHESION MOLECULE; NOTCH RECEPTOR; NOTCH3 RECEPTOR; PROLACTIN; PROTEIN DNAJ; PROTEIN P16; PROTEIN P8; PROTEIN TYROSINE PHOSPHATASE; PYRROLINE 5 CARBOXYLATE REDUCTASE; RAS PROTEIN; RNA 18S; TRANSCRIPTION FACTOR PIT 1; TRANSDUCIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; UVOMORULIN;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS; IMMUNOHISTOCHEMISTRY; MALE; MASS SPECTROMETRY; MICRODISSECTION; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROLACTINOMA; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSSPHENOIDAL SURGERY; TWO DIMENSIONAL ELECTROPHORESIS; UNITED STATES; UNIVERSITY HOSPITAL; UPREGULATION;

ADENOMA; ADULT; CLUSTER ANALYSIS; DNA, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PITUITARY NEOPLASMS; PROLACTINOMA; PROTEOMICS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM;

EID: 47249156807     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-007-0082-2     Document Type: Article

References (50)

1. Davis JR (2004) Prolactin and reproductive medicine. Curr Opin Obstet Gynecol 16(4):331-337
2. Forsyth IA, Wallis M (2002) Growth hormone and prolactin-molecular and function evolution. J Mammary Gland Biol Neoplasia 7:291-312
3. Ben-Jonathan N et al (1996) Extrapituitary prolactin: Distribution, regulation and clinical aspects. Endocr Rev 17(6):639-669
4. Berwaer M, Martial JA, Davis JR (1994) Characterization of an up-stream promoter directing extrapituitary expression of the human prolactin gene. Mol Endocrinol 8(5):635-642
5. Gellersen B et al (1994) Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma. Mol Endocrinol 8(3):356-373
6. Anderson B, Rosenfeld MG (2001) POU domain factors in the neuroendocrine system: Lesson from developmental biology provide insights into human disease. Endocr Rev 22:2-35
7. Verhelst J, Abs R (2003) Hyperprolactinemia: Pathophysiology and management. Treat Endocrinol 2(1):23-32
8. Herman V et al (1990) Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 71(6):1427-1433
9. Boikos SA, Stratakis CA (2007) Molecular genetics of the cAMP-dependent protein kinase pathway and of sporadic pituitary tumorigenesis. Hum Mol Genet 16 Spec No 1:R80-R87
10. Herman V et al (1993) Molecular screening of pituitary adenomas for gene mutations and rearrangements. J Clin Endocrinol Metab 77(1):50-55
11. Evans CO et al (2000) Screening for MEN1 tumor suppressor gene mutations in sporadic pituitary tumors. J Endocrinol Invest 23(5):304-309
12. Asa SL, Somers K, Ezzat S (1998) The MEN-1 gene is rarely down-regulated in pituitary adenomas. J Clin Endocrinol Metab 83(9):3210-3212
13. Satta MA et al (1999) Expression of menin gene mRNA in pituitary tumours. Eur J Endocrinol 140(4):358-361
14. Farrell WE et al (1999) Sequence analysis and transcript expression of the MEN1 gene in sporadic pituitary tumours. Br J Cancer 80(1-2):44-50
15. Orr RB, Kreisler AR, Kamen BA (1995) Similarity of folate receptor expression in UMSCC 38 cells to squamous cell carcinoma differentiation markers. J Natl Cancer Inst 87(4):299-303
16. Evans CO et al (2001) Novel patterns of gene expression in pituitary adenomas identified by complementary deoxyribonucleic acid microarrays and quantitative reverse transcription-polymerase chain reaction. J Clin Endocrinol Metab 86(7):3097-3107
17. Evans CO et al (2003) Differential expression of folate receptor in pituitary adenomas. Cancer Res 63(41):4218-4224
18. Moreno CS et al (2005) Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses. Cancer Res 65(22):10214-10222
19. Yu R, Melmed S (2001) Oncogene activation in pituitary tumors. Brain Pathol 11:328-341
20. Genkai N et al (2006) Increased expression of pituitary tumor-transforming gene (PTTG)-1 is correlated with poor prognosis in glioma patients. Oncol Rep 15(6):1569-1574
21. Stoika R, Melmed S (2002) Expression and function of pituitary tumour transforming gene for T-lymphocyte activation. Br J Haematol 119(4):1070-1074
22. Rehfeld N et al (2006) The influence of the pituitary tumor transforming gene-1 (PTTG-1) on survival of patients with small cell lung cancer and non-small cell lung cancer. J Carcinog 5:4
23. Tsai SJ et al (2005) Expression and functional analysis of pituitary tumor transforming gene-1 [corrected] in uterine leiomyomas. J Clin Endocrinol Metab 90(6):3715-3723
24. Asa SL, Ezzat S (1998) The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 19(6):798-827
25. Shimon I, Melmed S (1997) Genetic basis of endocrine disease: Pituitary tumor pathogenesis. J Clin Endocrinol Metab 82(6):1675-1681
26. Spada A, Faglia G (1996) G-protein dysfunction in pituitary tumors. In: Oncogenesis and molecular biology of pituitary tumors. M. S, Editor. Karger, Basel, pp 108-121
27. Irizarry RA et al (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4(2):249-264
28. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98(9):5116-5121
29. Zhan X, Desiderio DM (2003) A reference map of a human pituitary adenoma proteome. Proteomics 3:699-713
30. Zhan X, Desiderio DM (2003) Spot volume vs. amount of protein loaded onto a gel: A detailed, statistical comparison of two gel electrophoresis systems. Electrophoresis 24:1818-1833
31. Zhan X, Desiderio DM (2003) Differences in the spatial and quantitative reproducibility between two second-dimensional gel electrophoresis systems. Electrophoresis 24:1834-1846
32. Zhan X, Desiderio DM (2003) Heterogeneity analysis of the human pituitary proteome. Clin Chem 49(10):1740-1751
33. Herman JG et al (1996) Methylation-specific PCR: A noval PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93(18):9821-9826
34. Conway KE et al (2000) TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in hunan breast cancers. Cancer Res 60(22):6236-6242
35. Esteller M et al (1998) Inactivation of glutathione S-transferase P1 gene by promotor hypermethylation in human neoplasia. Cancer Res 58(20):4515-4518
36. Karavitaki N et al (2006) Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma. Clin Endocrinol (Oxf) 65(4):524-529
37. Garcia de la Torre N, Turner HE, Wass JAH (2005) Angiogenesis in prolactinomas: Regulation and relationship with tumor behaviour. Pituitary 8:17-23
38. Picard C et al (2007) Gs alpha overexpression and loss of Gs alpha imprinting in human somatotroph adenomas: Association with tumor size and response to pharmacologic treatment. Int J Cancer 121(6):1245-1252
39. Ruebel KH et al (2006) Patterns of gene expression in pituitary carcinomas and adenomas analyzed by high-density oligonucleotide arrays, reverse-transcriptase-quantitative PCR, and protein expression. Endocrine 29:435-444
40. Chen G, Courey A (2000) Groucho/TLE family proteins and transcriptional repression. Gene 249:1-16, [Review]
41. Plank MJ, Sleeman BD, Jones PF (2004) The role of the angiopoietins in tumour angiogenesis. Growth Factors 22:1-11
42. Ishitani A et al (2003) Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol 171(3):1376-1384
43. Barczyski M et al (2007) Posterior retroperitoneoscopic adrenalectomy: A comparison between the initial experience in the invention phase and introductory phase of the new surgical technique. World J Surg 31(1):65-71
44. Gotz R et al (2005) Bag1 is essential for differentiation and survival of hematopoietic and neuronal cells. Nat Neurosci 8(9):1169-1178
45. Morris DG et al (2005) Differential gene expression in pituitary adenomas by oligonucleotide array analysis. Eur J Endocrinol 153:143-151
46. Schade R et al (2007) Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med 356:29-38
47. Sarkar DK, Kim KH, Minami S (1992) Transforming growth factor-β1 mRNA and protein expression in the pituitary gland and its action on PRL secretion and lactropic growth. Mol Endocirinol 6:1825-1833
48. Minami S, Sarkar DK (1997) Transforming growth factor-B1 inhibits prolactin secretion and lactotropic cell proliferation in the pituitarty in the pituitary of estrogen-treated Fischer 344 rats. Neurochem Int 30:499-506
49. Mochizuki S, Okada Y (2007) ADAMs in cancer cell proliferation and progression. Cancer Sci 98:621-628
50. Ohtsuka T et al (2006) ADAM28 is overexpressed in human non-small cell lung carcinomas and correlates with cell proliferation and lymph node metastasis. Int J Cancer 118:263-273